10 Followers on Owler
PhoreMost is an England-based biopharmaceutical company that develops phenotypic screening platforms and antibody-based therapies to treat infectious diseases... Read more
OverviewCompetitorsFundingNews & Insights
PhoreMost is an England-based biopharmaceutical company that develops phenotypic screening platforms and antibody-based therapies to treat infectious diseases... Read more
Phoremost CEO: Neil Torbett

CEO

Neil Torbett

CEO Approval Rating

- -/100

2014

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology
8090 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$76.8M

News

Funding
Sep 11, 2024
tech_eu
Phoremost received $12M in Series B Funding

Phoremost Competitors

1Biolog
2Theolytics
3Ncardia
4Apexigen
5Crescendo Biologics
6Endocyte
7NovImmune
8Mironid
9MD Biosciences
10DiscoverX
Unlock 19 + competitors

Trending Companies